ARCHIVES

FDA Approves Erbitux for Head & Neck Cancer.

This article is from The Cancer Letter archive.

Vol. 32 No. 08 | March 3, 2006

Download PDF Visit The Full Archive

Related Articles

NCI Payline For Fiscal 1986 To Be 160 or 165

October 11, 1985

In Congress: Continuing Resolutions Keep Feds Running; Henney Nomination Stalled By Nickles

October 16, 1998

HHS Group To Study Policies Affecting Academic Centers

June 20, 1997

Obituary: Patricia Delaney, FDA Cancer Liaison.

June 6, 2008

WHI Investigators Reiterate: Breast Cancer, CHD Risks Too Great For Routine HT Use

November 2, 2002

Cullen To Leave NCI, Will Become Director Of AMC Cancer Center; Nixon May Join ACS

April 14, 1989